Depression Resources – Supporter

Overview

Perhaps you live with someone who has been depressed for so long that you can barely remember what life together felt like before. You love them, but their sadness, exhaustion, pessimism or lack of interest has become part of almost every day. A pleasant outing can feel like hard work. Good news receives little reaction. You make the plans, keep the household running, initiate affection and encourage them to see friends. Eventually, you may feel as though there are two people in the relationship but only one of you is actively living it.

This can be an extraordinarily lonely position. You may feel compassion, grief, impatience and anger at the same time. You might resent doing so much, then feel ashamed because the other person is genuinely ill. You may be frightened that, if you stop helping, they will deteriorate—or blame you for giving up on them.

This page concerns long-lasting or repeatedly recurring depression, not ordinary sadness following a difficult event. Chronic depression can affect the brain’s systems for pleasure, energy, motivation, attention, threat detection and social connection. Modern genetics, brain imaging and multiomics research show that people who share the label depression do not necessarily have the same underlying biology. What looks like a lack of effort or affection may reflect profound difficulty experiencing reward, starting actions or imagining a better future. It is not simply a bad mood (2025 genomic study; 2024 brain-biotype study).

That explanation matters, but so does the effect on you. Severe depression can narrow someone’s attention around their own pain. They may be unable to share your excitement, seem uninterested in your problems, or repeatedly return every conversation to what is wrong. That can feel self-centred from the outside without being narcissism or deliberate unkindness. Nevertheless, your feelings, career, friendships, sex life, finances and health matter too.

There is real hope in treatment. Antidepressants, structured psychotherapy and specialist interventions can improve chronic or recurrent depression, sometimes substantially. But there is no single “good medication” that works for everybody, and the first treatment may fail or cause unacceptable side effects. What you can reasonably ask for is a serious, continuing effort to find effective care, with clear reviews and next steps—not a promise to recover on command.

You can be loving without becoming someone’s unpaid full-time therapist, and you can encourage treatment without trying to control their body or decisions. A sustainable relationship needs care for both people. This page is for partners, friends, relatives, adult children and other supporters trying to find that balance.

On this page: Early warning signs · How to get diagnosed? · Life trajectory · Things you might need to work on · Workplace success · Family dynamics · Friendship & social skills · Intimate relationships · Self-help & coping · How it can be for Them to interact with You · Learn more (the Science) · Organisations · Resources · Other people like you

Early warning signs

Sometimes you do not notice the burden growing because each individual adjustment seems small. Watch for a pattern developing over months or years.

You are carrying most of the practical life. Appointments, food, finances, childcare, messages, holidays and difficult decisions repeatedly fall to you.
Your happiness needs to be hidden. You stop talking about a promotion, an enjoyable trip or a funny story because you know it may meet silence or a bleak response.
Every conversation returns to hopelessness. You listen carefully, offer ideas, and find yourselves having the same discussion again the next evening.
You feel rejected by someone who says they love you. Affection, sex, attention and shared interests have faded. They may be emotionally numb rather than less loving, but the loneliness is real.
You are monitoring their mood. A good morning feels like a small victory; a bad evening changes everyone’s plans.
You stop inviting people over. You fear your loved one will withdraw, seem uncomfortable or be hurt by ordinary social expectations.
You feel both indispensable and powerless. They depend on you for practical and emotional support, yet nothing you do seems to improve the depression for long.
You are becoming unwell yourself. Poor sleep, irritability, anxiety, loss of pleasure, concentration problems, headaches or dread of going home deserve attention.
Treatment has become a forbidden subject. You are afraid to ask about appointments, medication or progress because the conversation ends in shame, anger or silence.

Look separately for warning signs in the depressed person: worsening hopelessness, withdrawal, neglect of basic needs, increased substance use, statements that others would be better off without them, or talk of death or suicide. Take these seriously, particularly after abrupt changes in behaviour, a crisis, or a treatment change.

If you suspect suicidal thoughts, ask directly and listen. Asking about suicide does not create suicidal thoughts. If there is immediate danger, an active plan with intent, or you cannot keep the situation safe, contact local emergency or urgent mental-health services. Do not promise to keep a dangerous situation secret or assume you must manage it alone (NIMH guidance).

How to get diagnosed?

You do not need to diagnose someone yourself or persuade them to accept a label. What matters is whether the symptoms are persistent, impairing and properly assessed. A useful first appointment can begin with a clear account of how the person sleeps, eats, thinks, works, experiences pleasure, relates to others and functions at home—and how long this has been happening.

With their permission, you may help describe changes that are hard for them to notice: repeatedly missing work, losing interest in a favourite activity, no longer completing ordinary tasks, or withdrawing from family life. Bring a short timeline, including earlier periods of recovery and previous treatments with their benefits or side effects. Your role is to provide information, not to act as a prosecutor or speak over them.

The clinician should consider whether symptoms reflect persistent depression, repeated episodes, bipolar-spectrum illness, another psychiatric condition or a relevant physical problem. Thyroid disease, anaemia, sleep disorders, medication effects, chronic pain and substance use can complicate the picture. Bipolar-spectrum features such as episodes of unusually high energy or needing very little sleep matter because they can change treatment decisions.

Genetic scores, brain-circuit imaging, inflammatory proteins and metabolomic signatures are genuine areas of depression research. At present, they do not provide a dependable routine test that can tell a family which biological depression subtype their relative has or which treatment will work best. Some pharmacogenetic tests can inform how particular antidepressants are metabolised, especially after troublesome side effects or unusual responses, but they do not diagnose depression or guarantee a drug’s benefit.

It is reasonable to ask the clinician, ideally together: What have we ruled out? What is the treatment goal? When will we review it? If this does not work, what is the next option? You are also entitled to seek care for your own anxiety, low mood, exhaustion or stress—even if the depressed person is not ready for treatment.

Life trajectory

Chronic depression can change the course of an entire household. Holidays are postponed, social life shrinks, careers are constrained, savings are used up, and children learn to be quiet when a parent is having a difficult day. The supporter may gradually become the organiser, breadwinner, emotional companion and crisis manager. Some people stay in this arrangement for decades; others eventually separate or renegotiate the relationship.

This is not merely anecdotal. A 2025 interview study of 28 people with persistent depressive disorder and nine caregivers documented loneliness, resentment, loss of shared identity, changed family roles and the strain of taking over responsibilities. It is small and cannot tell us how common those experiences are. In a separate longitudinal study of 1,699 couples, changes in depressive symptoms predicted later changes in relationship satisfaction; the relationship was more consistent in that direction than the reverse after the researchers used models separating stable differences between couples from changes within couples (Solis and colleagues, 2025; Mund and colleagues, 2024).

You may reasonably worry about your own future. Years of disrupted sleep, financial strain and isolation are not harmless. But there is no validated number of years of life lost simply because someone supports a chronically depressed partner. The practical point is to prevent your own health and opportunities from deteriorating while the illness is being addressed.

Treatment changes the possibilities. When depression improves, people may regain initiative, concentration, pleasure, affection and the ability to take responsibility. Some couples rediscover a good relationship; others find that problems remain, and need attention in their own right. Remission is possible, but relapse can occur and some people require several treatment steps. A good long-term plan includes both active care now and a strategy for spotting deterioration later.

The most concerning pattern is not a person being very ill; it is years of serious impairment with no workable plan, no review of what has failed, and an expectation that you will absorb every consequence indefinitely. You cannot make another adult engage in treatment, but you can decide what help you can realistically continue to provide.

Things you might need to work on

Being kind and being effective are not exactly the same thing. Many devoted supporters try harder and harder, until care becomes constant persuasion, rescuing or argument. These approaches can leave everyone demoralised.

Separate their illness from your responsibilities. You can acknowledge that getting out of bed is genuinely difficult while still agreeing how meals, bills and childcare will be managed.
Replace repeated encouragement with specific offers. “Would you like me to book an appointment with you?” or “Shall I drive you there?” is more useful than another long speech about getting better.
Agree on a treatment review rather than another promise. Try: “I know the last medicine was awful. Could we talk to the prescriber about what else is available? I can’t keep managing everything as we have been.”
Put limits around circular conversations. Listening matters, but you need not discuss the same hopeless predictions for three hours every night. “I can listen for a while; then I need to rest. Let’s write down the concern for your appointment.”
Keep invitations small and pressure low. A 15-minute walk, an easy meal with a friend or sitting outside together may be more achievable than a full social weekend. Invite without demanding enjoyment.
Allow the person to do what they can. Taking over every task may be necessary during a crisis, but over time it can reduce opportunities for independence. Negotiate realistic contributions and review them as symptoms change.
Express your needs plainly. “I miss talking about my day,” “I need you to take our child to school on Tuesdays if you can,” or “I need one evening with friends each week” is more useful than accumulating silent resentment.
Protect against becoming their only support. Encourage a wider network of friends, clinicians and family when possible. You need somewhere to put your own worry, too.

There is an important difference between not being able to follow through and not being willing to discuss any way forward. Depression may impair motivation and judgement; medication side effects or past treatment failures can also make people understandably wary. Nevertheless, the supporter’s limits remain valid. You may say what you can offer and what you cannot, without threatening, humiliating or trying to force treatment.

Workplace success

Your own work can suffer when home becomes unpredictable. You may arrive tired after a night of worry, leave meetings to answer urgent calls, turn down travel or promotions, or take on more paid work because the household has lost income. You may become the person who is always available to manage appointments, food and finances.

It is worth noticing these costs early. If you work outside the home, consider whether flexible hours, predictable appointments, remote days or time-limited leave are available where you live. You need not disclose every intimate detail to an employer; it may be enough to say that you have significant family care responsibilities. Seek financial or employment advice if bills, debt or benefits become difficult.

Protect a few things that are yours: uninterrupted work time, sleep, an important professional opportunity or an activity you value. Your career is not a less worthy life project because someone close to you is ill. If they improve with treatment, a return to a fairer division of responsibilities may be one of the most meaningful measures of recovery.

If you are supporting a friend or colleague rather than a partner, you can make space for flexible arrangements without quietly absorbing their entire job. Clear priorities, agreed coverage and appropriate occupational or clinical support tend to be more sustainable than indefinite informal rescue.

Family dynamics

Different family relationships create different pressures. A partner may be the one who hears every bleak thought, pays the bills and keeps the children cheerful. A parent may watch an adult child become isolated and feel desperate to intervene. An adult child may have grown up learning to monitor a parent’s mood and never quite feel free to live independently.

Children need particular protection. Explain in age-appropriate language that a parent’s depression is a health problem and is not the child’s fault. Keep routines, school, friendships and trusted adults in place. A child can be helpful in ordinary family ways, but should not become the parent’s counsellor, crisis monitor or main reason for staying alive. A large 2025 study following 8,888 UK families linked sustained parental psychological distress during childhood with more depressive symptoms in their children at age 14; it was observational, so it does not mean any one child is destined to develop depression (2025 cohort study).

Other relatives may make the situation harder without meaning to. They might say the person needs more willpower, sunshine or gratitude; alternatively, they might expect you to be endlessly understanding while offering little practical help. It is reasonable to ask for specific contributions: one meal each week, a lift to an appointment, a regular visit, childcare, or someone who checks in on you.

If one person repeatedly behaves harshly, uses threats or controls others, do not explain those actions away as depression. Irritability can be a symptom; intimidation and abuse still require protection and boundaries. Joint counselling is not a substitute for safety when coercion or violence is present.

Friendship & social skills

Friends are often among the first things a supporter loses. You cancel dinners because your partner is having a bad evening. You decline holidays because they cannot imagine enjoying them. You become embarrassed about inviting people over, or so tired that you simply stop reaching out.

Some friends will not understand why you stay; others will not understand why you need distance. You may avoid talking about the situation because it feels disloyal. Meanwhile, the depressed person may rarely contact friends or join events, leaving you to maintain both social lives.

Try not to make every friendship conditional on the depressed person’s participation. See a friend alone. Go to a concert or family gathering even if they choose not to come, provided any immediate safety and care needs are appropriately covered. You can enjoy yourself without pretending the situation at home is easy.

For a friend who is depressed, small, regular, low-pressure contact can be valuable. A message saying, “I’m thinking of you; no need to reply,” or an invitation to join a short walk is often more sustainable than an elaborate attempt to cheer them up. Friendship still has two sides, however. It is acceptable to protect your time when every exchange becomes a crisis conversation or your own needs are repeatedly ignored.

You may need different friends for different things: someone who understands illness, someone who can offer practical help, and someone with whom you can simply laugh and have an ordinary evening. All three matter.

Intimate relationships

Depression can turn a loving partnership into an arrangement that feels more like caregiving than romance. The depressed person may lose interest in sex, affection, conversation, travel or shared ambitions. They may not be able to feel the pleasure they once felt, even when they still love you. Some antidepressants can also affect libido, sexual functioning or emotional responsiveness; those effects should be discussed with the prescriber rather than silently endured.

From your side, this may feel like being unwanted. You might hesitate to ask for affection because you do not want to pressure someone who is suffering. Resentment can build when you are expected to provide tenderness, reassurance and practical care, but receive little attention in return. It is possible to be compassionate and still grieve the relationship you are missing.

Try to discuss what is possible now rather than whether either of you is a good partner. Perhaps the person can manage holding hands but not sex, a short conversation but not a crowded dinner, one household task but not five. Agreements should leave room for symptoms to fluctuate—and for your needs to be acknowledged. Neither person owes sex; both are entitled to talk honestly about physical and emotional intimacy.

Where both partners are willing, couples therapy can be useful alongside treatment for depression, particularly when conflicts, withdrawal or unfair responsibilities have developed. Recent trials suggest couple-based approaches can reduce depressive symptoms, although the evidence base is small and not focused entirely on chronic depression (2025 meta-analysis). It cannot replace specialist depression care or make an unsafe relationship safe.

If treatment is repeatedly refused, or you remain responsible for nearly everything over a long period, you may have to decide what kind of relationship you can live in. The decision to stay, renegotiate, live separately or leave is not determined by how biologically real the illness is. Your safety, dignity and ability to have a future are relevant too.

Self-help & coping

What tends to help

Encourage a real treatment plan. A first appointment, a review date and a next step if treatment fails matter more than vague promises to “try harder”. Offer practical help with booking, transport or remembering questions if the person wants it. Encourage them to tell clinicians honestly about adverse effects and previous attempts.

Know the main treatment options. Structured therapies such as cognitive behavioural therapy (CBT), behavioural activation and CBASP (designed particularly for chronic depression) can help. Antidepressants help many people, but not everyone responds to the first drug. Combining psychotherapy and medication may be appropriate for more severe or persistent illness. When initial approaches do not work, specialist options may include changing or adding medication, rTMS, ECT, or supervised ketamine/esketamine in suitable settings. Some approaches have stronger evidence than others, and availability varies by country (NICE treatment guideline; CANMAT guideline).

Discuss treatment as shared problem-solving. “You looked exhausted on that drug and I understand why you stopped. Could we ask about a different one?” will often go further than “You refuse to get better.” If an antidepressant previously worked, stopping it can increase relapse risk for some people, but decisions about continuing or tapering belong with the person and prescriber. Abrupt stopping can cause withdrawal symptoms.

Use small routines rather than a constant motivational campaign. An agreed bedtime, manageable physical activity, a meal, daylight, short social contact or one shared task may help create a more workable day. These can complement treatment; they are not reliable substitutes for care in severe chronic depression.

Keep some conversations free of depression. Watch a programme, talk about music, tend a plant, or share an ordinary joke without assessing whether the person is happier yet. You are allowed to have a relationship with a person, not only with their symptoms.

Get support of your own. A therapist, GP, caregiver group, trusted friend, relative or practical respite arrangement can help you think more clearly. If you have become depressed or anxious yourself, that deserves treatment on its own merits.

What often backfires—or has little evidence

Arguing someone into optimism. “You have so much to be grateful for” rarely resolves biological anhedonia or persistent hopelessness. It may increase shame or conflict.
Repeating the same hopeless discussion for hours. Listening is important. Spending hours repeatedly analysing why nothing can improve may leave both people more distressed. In a 2025 longitudinal study of community couples, repeatedly dwelling on problems together was associated with subsequent emotional distress; this is an association, not proof that one conversation causes depression (2025 couples study).
Taking over everything forever. Necessary help during severe illness may become unsustainable if responsibilities are never reassessed.
Monitoring, hiding or forcing medication. There is no good evidence that coercive family policing is an effective treatment for chronic depression. It can damage trust and may be dangerous. Consent and professional supervision matter.
Miracle diets, supplements, hormone tests, retreats or psychedelic self-treatment. Some interventions have emerging research; others have little credible evidence. Even where medically supervised psychedelic or ketamine treatments show benefit in selected patients, that does not justify unregulated use or promise a cure. Neither you nor your loved one should have to gamble your finances or safety on a commercial miracle.
Assuming love or patience is enough. Support can make treatment easier; it cannot replace it.

If the person will not seek help

Ask what is stopping them: fear, an earlier humiliating experience, medication side effects, cost, hopelessness, transport, a belief that they are not ill, or simple exhaustion. Different barriers call for different solutions. You can offer a single manageable next step and revisit it calmly.

If there is no immediate danger and they continue to decline, avoid an exhausting cycle of daily arguments. State your own limits clearly: “I love you and want us to have a good life. I can help with appointments and practical things, but I cannot be the only person carrying our household or talking about depression every night. I need us to find more support.” Their right to make treatment choices does not require you to surrender yours.

If you fear suicide, act on the safety concern rather than debating medication. Ask about thoughts, intent and plans; connect them with urgent professional help; and seek emergency services if there is imminent risk. Where feasible, develop a crisis plan when the person is comparatively well, including warning signs, clinicians to contact and who can help. You are part of a support network, not a substitute for one.

How it can be for Them to interact with You

Other people may see you as patient and strong. They may not notice how much you do behind the scenes, or that you have stopped expecting good things for yourself. Some may think you are too accommodating; others may judge you for wanting a holiday alone, expressing anger or considering separation.

You may become unusually alert to other people’s moods. You may over-explain your loved one’s cancellations, worry about leaving them home alone, or feel responsible for protecting their reputation. Even ordinary enjoyment can come with guilt: How can I have a lovely evening when they are suffering?

You may also discover a part of yourself you do not particularly like: impatience with sadness, irritation at small requests, the urge to avoid coming home. Those feelings do not mean you are a bad person. They may be signs that your resources have been stretched beyond what you can keep offering.

It can help to tell your own supporters what you need, without sharing private details the depressed person has asked you to keep confidential: “I’m doing a lot of care at home and need company,” “Could you help with the children once a week?” or “Please don’t tell me simply to leave or to be more patient; I need someone who will listen.”

A genuinely good outcome is not that you become infinitely resilient. It is that the depressed person receives effective treatment and a chance to build a more satisfying life, while you retain enough freedom, companionship and support to enjoy yours.

Learn more (the Science)

Scope: chronic depression and why one label contains different biology

The evidence in this page combines studies specifically recruiting persistent or chronic major depression with broader cohorts of recurrent major depressive disorder (MDD) and community samples reporting depressive symptoms. These are overlapping but non-identical groups. Results from couples with temporary depressive symptoms cannot be treated as precise prognosis for a person with severe lifelong depression.

Depression is substantially polygenic and biologically heterogeneous. A large 2025 trans-ancestry GWAS included 688,808 depression cases and 4,364,225 controls, finding 697 associations across 635 loci and prioritising 308 high-confidence gene associations. Functional analyses implicated excitatory and inhibitory neurons, synaptic processes, and drug-relevant signalling. Its best reported polygenic scores accounted for up to 5.8% of liability variance in European-ancestry datasets—not enough to diagnose a particular individual or choose a specific medication (2025 Cell GWAS).

Functional MRI and machine learning also reveal candidate subgroups. A 2024 Nature Medicine study used task-based and resting-state circuit scores in 801 people with depression and anxiety, describing six biotypes, with treatment-outcome data in 250 participants. In 2025, a separate imaging-plus-multiomics study of 327 patients and 480 controls described profiles including a synaptic/genetic group and another associated with IL-1β inflammatory signalling. A blood metabolomics study of 7,945 people with current depression, using 249 measurements, identified three lipid-related profiles. These are biologically informative attempts to split a broad diagnosis into subgroups, but require replication and treatment trials before a relative can responsibly be told that a scan or blood panel will select the best treatment (Tozzi et al., 2024; Tang et al., 2025; Ma et al., 2025).

The practical lesson for families is double-edged. Symptoms are rooted in altered biological functioning, not simply weak willpower. Equally, biological differences can help explain why two people respond differently to the same treatment. A failed medication is not evidence of dishonesty, but persistent failure should trigger a better assessment and another evidence-based plan.

What depression does to partners and families

Persistent depression: qualitative evidence. Solis and colleagues interviewed 28 people with persistent depressive disorder and nine informal caregivers in the Netherlands (2025). Themes included powerlessness, changes in the patient’s identity, family suffering, relationship dissatisfaction, isolation, shame and caregiver resentment. Caregivers described taking on household and childcare responsibilities and feeling emotionally alone. Their sample was small and selected; quotations illustrate mechanisms rather than rates of harm (2025 primary study).
Relationship changes: dyadic longitudinal modelling. Mund and colleagues analysed 1,699 mixed-gender couples in the German Family Panel (2024). Models accounting for stable differences between individuals found that within-person increases in depression predicted lower subsequent relationship satisfaction, whereas the reverse temporal link was less convincing. This supports a plausible direction of strain, not proof that depression alone causes a specific relationship outcome (2024 primary study).
Different couple trajectories. In 2,130 older married couples from the US Health and Retirement Study (observations 2002–2020; published 2025), researchers identified a group with relatively elevated symptoms in husbands and not wives (13.6%), another with elevated symptoms in wives and not husbands (16.1%), and a lower-symptom group (70.3%). These are statistical trajectories of symptoms, not prevalence of diagnosed chronic depression. Not all couples develop matching depression (2025 study).
Repetitive negative talk. A 2025 study of 960 romantic couples found that higher couple co-rumination predicted increases in depression and anxiety measures at follow-up, while not predicting a change in relationship satisfaction. As an observational analysis over two waves, it cannot show that restricting a distressed person’s talk will treat depression. It does support testing a balance between listening and time-limited problem-solving (2025 study).
Children and intergenerational risk. A 2025 analysis of 8,888 UK families associated parental psychological distress across childhood with higher adolescent depressive symptoms. It does not establish inevitability or separate genetic transmission from shared household circumstances; supporting both parents and maintaining a stable caregiving network are reasonable clinical priorities (2025 cohort).

Do interventions involving families actually help?

Family psychoeducation: A 2022 systematic review and meta-analysis included five randomised studies involving 301 adults with MDD and their families. Relative to usual care, psychoeducation was associated with modest-to-moderate improvements in patients’ symptoms at approximately 16 weeks (standardised mean difference −0.52, 95% CI −1.03 to −0.01) and at final follow-up (−0.53, 95% CI −0.98 to −0.08). Results for family functioning were not statistically significant. Importantly, all outcomes received very low GRADE certainty ratings, so these are not dependable estimates of what an individual family should expect (Katsuki et al., 2022).

Supporter outcomes may be much harder to improve: In a trial specifically involving chronic major depression, 49 patient-family units were randomised to four multifamily psychoeducation sessions or one counselling session. The prespecified primary outcome—relatives’ psychological distress at 16 weeks—showed no statistically significant benefit (mean difference 1.17 points, 95% CI −0.63 to 2.98). Some exploratory outcomes improved, but these do not overturn the null primary result (Katsuki et al., 2018).

A newer Danish randomised trial, reported in 2026, assigned 89 relatives of adults with MDD to four weeks of psychoeducation or a time-matched support group. There was no significant overall intervention effect on relatives’ well-being or family attitudes; a single family-functioning domain improved briefly. Exploratory differences between supporter subgroups were too small and uncertain to guide individual selection. This is valuable negative evidence: knowing more about depression is helpful, but knowledge alone may not relieve the practical and emotional burden of caring (Ipsen et al., 2026).

Couple-based treatment: A 2025 meta-analysis of five randomised trials involving 193 couples reported a moderate pooled improvement in depressive symptoms (SMD −0.60, 95% CI −0.88 to −0.33). Trials were relatively few and did not isolate chronic depression or establish long-term protection for supporters. Where both people want to work on the relationship, couple-based treatment is a reasonable adjunct; it is not a substitute for treating an individual depressive disorder (Chen and colleagues, 2025).

Collaborative clinical care: A 2025 individual-participant-data meta-analysis of 20,046 patients from primary-care collaborative-care trials identified structured psychotherapy and planned family involvement among components associated with stronger treatment effects. It studied intervention packages, not the independent effect of a supportive spouse. Its implications are about creating a coordinated clinical system in which the family can participate with consent, not shifting treatment responsibility onto relatives (Schillok et al., 2025).

Does taking the right medication improve the family’s prospects?

When a medicine works and is tolerated, relief of core symptoms should make reciprocal social and household functioning more feasible. But drug response is heterogeneous; no medication has demonstrated a universal restoration of empathy, pleasure, sexual function and family roles in chronic depression.

The first antidepressant may not work. The 2025 DEPRE’5 randomised trial studied 257 adults whose depression had not responded to a selective serotonin reuptake inhibitor (SSRI). At six weeks, four pooled alternative strategies—lithium augmentation, nortriptyline combination, switching to venlafaxine, or adding problem-solving therapy—had a 28.2% response rate, versus 14.3% after optimising the original SSRI dose (OR 2.36, 95% CI 1.0–5.6; p = 0.05). Remission rates (16.9% versus 12.2%) were not significantly different. This is evidence for reviewing a failing treatment, not for one particular universally superior drug or guaranteed recovery (2025 trial).
Stopping a drug that has worked carries risk. In the ANTLER randomised trial of 478 primary-care patients well enough to consider stopping long-term antidepressants, 52-week relapse occurred in 39% assigned to maintenance versus 56% assigned to tapering and discontinuation. This result applies to previously stabilised patients, not to someone who never benefited from the medication; withdrawal symptoms and imperfect adherence also complicate interpretation. It supports discussing discontinuation with a clinician, not blanket lifelong prescribing (Lewis et al., 2021).
Treatment review should be active. NICE recommends checking improvement, adverse effects and safety within 2–4 weeks, and reassessing limited response rather than continuing an ineffective plan indefinitely. For chronic presentations, care may also involve CBT, CBASP, combined treatment and, when clinically appropriate, specialist neuromodulation or rapid-acting medication. Evidence and risks differ considerably across interventions (NICE NG222; CANMAT 2024).
Precision medicine has begun, but it is not complete. Antidepressant-metabolism gene variants such as CYP2D6, CYP2C19 and CYP2B6 can provide drug-specific dosing or selection information for certain medicines. They generally predict exposure or tolerability better than whether a person’s chronic depression will remit. Biomarker-informed treatment matching based on inflammation, MRI or metabolomics remains an important research goal rather than an established family-level decision tool (CPIC 2023).

There is no randomised evidence showing that pressure, guilt, medication policing or an ultimatum from a partner reliably improves antidepressant response. A supporter can help overcome barriers and ask for a serious treatment process; the choice and monitoring of treatment belong with the patient and qualified clinician. Conversely, the supporter is not required to sustain an intolerable level of care indefinitely because the patient declines every available avenue of help.

Safety and the limits of supporter responsibility

Supporters should not be asked to handle suicide risk alone. The US National Institute of Mental Health recommends asking directly about suicidal thoughts, listening without judgement, helping reduce immediate access to lethal means where it is safe to do so, connecting the person with professional or crisis support, and following up. High-risk situations require urgent clinical or emergency action (NIMH, revised 2024).

There is currently no validated biological test that predicts which depressed person will recover, which spouse will develop caregiver burnout, or which family support strategy will be most effective for a specific genetic subtype. You can nevertheless track real-world progress: the depressed person’s activity, sleep, pleasure, social contact, safety and treatment engagement, plus the supporter’s sleep, health, free time, finances and sense of companionship. Both sets of outcomes matter.

Organisations

Mind (UK): How to help someone with depression — practical, compassionate advice for friends and relatives, including looking after yourself.
NAMI: Family-to-Family — education and peer support for family members and other supporters of people with mental-health conditions; availability varies.
Depression and Bipolar Support Alliance (US) — peer support and resources for people with mood disorders and those who care about them.
Carers UK — information on finances, rights, practical support and emotional strain for unpaid carers.
NIMH: Five action steps for suicide prevention — clear guidance on responding when someone may be suicidal.
NICE: Depression in adults — detailed evidence-based recommendations on assessment, treatment, follow-up and relapse prevention.
Befrienders Worldwide — directory of emotional-support services in multiple countries.

These services differ in location, accessibility and eligibility. For immediate danger, contact your local emergency number or urgent mental-health service.

Resources

Selected primary studies and clinical guidance for readers who want to examine the evidence:

Biology and precision medicine: 2025 multi-ancestry depression GWAS; 2024 MRI/AI-derived biotypes; 2025 imaging/multiomics subtypes; 2025 blood metabolomic profiles; 2023 CPIC antidepressant pharmacogenetics.
What chronic depression does to families: 2025 interviews with patients with persistent depression and caregivers; 2024 longitudinal dyadic analysis of depression and relationship satisfaction; 2025 older-couple depressive trajectories; 2025 co-rumination and couples’ emotional distress; 2025 UK parent–child distress cohort.
Family and couple interventions: 2022 five-trial family psychoeducation meta-analysis; 2018 randomised trial involving relatives of people with chronic depression; 2026 relative well-being RCT; 2025 five-trial couple-based intervention meta-analysis; 2025 collaborative-care individual-participant meta-analysis.
Treatment when one approach is not enough: 2025 DEPRE’5 randomised trial; ANTLER maintenance/discontinuation trial; NICE depression treatment and relapse prevention; CANMAT 2024 guidance.
What to do in a crisis: NIMH suicide-prevention guidance.

The companion Depression – Myself page explains chronic depression from the person’s own perspective: what it feels like, genetic and multiomic findings, biomarkers, possible biological subtypes and available treatments. The two pages are intended to be read together, so that compassion for the depressed person does not erase the needs of those close to them.

Other people like you

You may recognise yourself in the partner who feels strangely happy on the evenings they are alone; the daughter who calls every day but dreads the conversation; the friend who keeps inviting someone and is hurt by years of silence; or the parent who loves an adult child fiercely but can no longer fund their entire life.

You may also know the relief of seeing treatment begin to work. Perhaps they laugh at something again, initiate a plan, notice your tiredness, make breakfast, or ask how your day was. These apparently small moments can mean an enormous amount, because they suggest that the person is beginning to rejoin a shared life.

Some supporters discover a workable balance through treatment, practical agreements, separate hobbies and outside help. Others conclude that the relationship cannot remain as it is. Both experiences belong in an honest account of chronic depression.

You are allowed to love the person, believe that their suffering is biologically real, and still say: “I need a life as well.” That is not a betrayal. It is part of finding a situation in which everyone has a realistic chance of health, dignity and happiness.

We would welcome your experience. What has reduced the burden in everyday life: a medicine that finally worked, structured therapy, agreed responsibilities, family sessions, shorter conversations about symptoms, or more help from outside? What looked promising but did not help? In sharing, please protect other people’s privacy and your own.

If you believe someone is in immediate danger of suicide or serious harm, seek urgent professional or emergency help. Supporters who are becoming unwell deserve assessment and care in their own right.